PAG
PLXP

Private Advisor Group’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Private Advisor Group’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,695
Closed -$3.47K – 2116
2023
Q1 		$3.47K Buy
26,695
+12,970
+94% +$2.64K ﹤0.01% 1955
2022
Q4 		$2 Hold
13,725
– – ﹤0.01% 1670
2022
Q3 		$9K Sell
13,725
-600
-4% -$884 ﹤0.01% 1893
2022
Q2 		$35K Sell
14,325
-36,775
-72% -$102K ﹤0.01% 2038
2022
Q1 		$206K Buy
51,100
+19,875
+64% +$109K ﹤0.01% 1878
2021
Q4 		$250K Buy
31,225
+1,750
+6% +$20.5K ﹤0.01% 1825
2021
Q3 		$569K Buy
29,475
+4,400
+18% +$76.9K ﹤0.01% 1454
2021
Q2 		$346K Buy
25,075
+1,550
+7% +$18.4K ﹤0.01% 1569
2021
Q1 		$212K Buy
+23,525
New +$172K ﹤0.01% 1710
2020
Q3 		– Sell
-25
Closed – – 3689
2020
Q2 		$0 Buy
+25
New +$76 ﹤0.01% 3958

Other funds holding PLXP

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Private Advisor Group's PLXP Position: Q2 2023 in Review

Private Advisor Group sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 26,695 shares — an estimated $3.47K sold.

Private Advisor Group first reported a position in PLXP in Q2 2020 and held it in 10 quarters. The position peaked at $569K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

  • Private Advisor Group reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Private Advisor Group sold 26,695 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $3.47K.
  • Private Advisor Group first reported a position in PLx Pharma Inc. Common Stock in Q2 2020 and held it in 10 quarters.
  • Private Advisor Group's PLx Pharma Inc. Common Stock position peaked at $569K in Q3 2021.
  • 4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.